Onderneming Acura Pharmaceuticals, Inc.
Aandelen
ACUR
US00509L8028
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,0041 USD | +36,67% | 0,00% | +4.000,00% |
Vakgebied
Verkoop per activiteit
USD in miljoen | 2020 | Gewicht | 2021 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 4 | 100,0 % | 2 | 100,0 % | -56,22% |
Verkoop per regio
USD in miljoen | 2020 | Gewicht | 2021 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 4 | 100,0 % | 2 | 100,0 % | -56,22% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Robert Jones
CEO | Chief Executive Officer | 65 | 07-04-08 |
Peter Clemens
DFI | Director of Finance/CFO | 71 | 01-02-98 |
Bob Seiser
AUD | Comptroller/Controller/Auditor | 60 | 01-03-98 |
Albert Brzeczko
PRN | Corporate Officer/Principal | 67 | 01-02-09 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Peter Clemens
DFI | Director of Finance/CFO | 71 | 01-02-98 |
Bruce Wesson
BRD | Director/Board Member | 81 | 01-03-98 |
William Skelly
BRD | Director/Board Member | 73 | 01-05-96 |
Director/Board Member | 53 | 01-12-02 | |
George Ross
BRD | Director/Board Member | 82 | 01-01-08 |
Robert Jones
CEO | Chief Executive Officer | 65 | 07-04-08 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 66 001 783 | 9 642 826 ( 14,61 %) | 0 | 14,61 % |
Bedrijfsgegevens
Acura Pharmaceuticals, Inc.
616 N. North Court Suite 120
60067, Palatine
+847 705 7709
http://www.acurapharm.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+4.000,00% | 272K | |
+7,52% | 111 mld. | |
+11,38% | 106 mld. | |
-12,64% | 22,24 mld. | |
+0,44% | 21,25 mld. | |
-4,18% | 18,97 mld. | |
-37,85% | 18,52 mld. | |
-8,58% | 16,81 mld. | |
+37,41% | 12,54 mld. | |
-23,95% | 8,09 mld. |
- Beurs
- Aandelen
- Koers ACUR
- Onderneming Acura Pharmaceuticals, Inc.